Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr.

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) — Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Arla Foods Ingredients protein soda concept Consumers are increasingly seeking functional beverages that support active,

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) — Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Arla Foods Ingredients protein soda concept Consumers are increasingly seeking functional beverages that support active,

AARHUS, Denmark, May 07, 2025 (GLOBE NEWSWIRE) — Arla Foods Ingredients will highlight the functional benefits of pure BLG (beta-lactoglobulin) in a new protein soda concept at Vitafoods Europe. Arla Foods Ingredients protein soda concept Arla Foods Ingredients protein soda concept Consumers are increasingly seeking functional beverages that support active,